PTC Therapeutics Inc. (PTCT) Has Plunged To A New Low On FDA News

PTC Therapeutics Inc. (PTCT) announced Tuesday morning that it has received a Refuse to File letter from the FDA regarding its New Drug Application for Translarna. The letter stated that the application was not sufficiently complete to permit a substantive review.

from RTT - Momentum http://ift.tt/1oF2DID
via IFTTT